provides funding for

• A comparative study of PF-06438179/GP1111 (an infliximab biosimilar) and reference infliximab in patients with moderate to severe active rheumatoid arthritis: A subgroup analysis  Article
• The Presence of Alpha-Synuclein in Skin from Melanoma and Patients with Parkinson's Disease  Article